Cellromax CO., Ltd. agreed to acquire Hanwha Plus No3 Special Purpose Acquisition Company from T.S. Investment Corporation and others in a reverse merger transaction for KRW 2.78 billion

Cellromax CO., Ltd. agreed to acquire Hanwha Plus No3 Special Purpose Acquisition Company (KOSDAQ:A430460) from T.S. Investment Corporation (KOSDAQ:A246690) and others in a reverse merger transaction for KRW 2.78 billion on April 24, 2024. Upon completion, Cellromax CO., Ltd. will survive the merger and will get listed on Korean stock exchange.Hanwha Plus No3 Special Purpose Acquisition Company will issue 1.258369 shares. The transaction is expected to close on September 24, 2024.